News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli L.A. McKeown October 27, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Daily News SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry Yael L. Maxwell October 20, 2023
News Conference News EACTS 2023 AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair Michael O'Riordan October 09, 2023
News Conference News TVT 2023 Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI Shelley Wood June 14, 2023
News Conference News EHRA 2023 EPs Push for More Involvement in TAVI Heart Team Discussions Michael O'Riordan April 21, 2023
News Conference News ACC 2023 Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients Todd Neale March 05, 2023
News Conference News CRT 2023 New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR Yael L. Maxwell March 03, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Daily News Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis Todd Neale January 20, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Conference News PCR London Valves 2022 Registry Results See Less PVL, Pacemakers With Acurate neo2 Shelley Wood November 29, 2022
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Daily News Early LV Recovery After TAVI Points to Better 5-Year Survival Yael L. Maxwell August 01, 2022
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Good Results For TAVI in Bicuspid Valves, but Questions Persist Michael O'Riordan March 08, 2022